BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20551825)

  • 1. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
    Sica G; Yoshizawa A; Sima CS; Azzoli CG; Downey RJ; Rusch VW; Travis WD; Moreira AL
    Am J Surg Pathol; 2010 Aug; 34(8):1155-62. PubMed ID: 20551825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
    Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
    Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
    Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
    Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
    Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.
    Xu L; Tavora F; Burke A
    Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
    Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
    J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNM stage is the most important determinant of survival in metachronous lung cancer.
    Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
    Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register.
    Puente J; López-Tarruella S; Ruiz A; Lluch A; Pastor M; Alba E; de la Haba J; Ramos M; Cirera L; Antón A; Llombart A; Plazaola A; Fernández-Aramburo A; Sastre J; Díaz-Rubio E; Martin M
    Breast Cancer Res Treat; 2010 Jul; 122(2):591-600. PubMed ID: 20063196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
    Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
    Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.